Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I find MedCity News a great resource for taking the pulse of the market and sourcing potential investment opportunities.”

Bernie Rudnick, Angel investor and advisor, CapGenic Advisors, LLC


Sign up for our daily newsletter


Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary

4:41 pm by | 0 Comments

Neurostimulation device company Neuros Medical Inc. has landed $3.5 million in its second round of funding from a handful of investors including medical device powerhouse Boston Scientific (NYSE:BSX).

The company’s device, called the Electrical Nerve Block, comprises a pacemaker-sized generator and a lead that wraps around a peripheral nerve, and delivers stimulation to block pain. The four-year-old company will use the money to add staff and continue testing of the Electrical Nerve Block, it said in a statement.

Last year, the company completed the first in-man feasibility study of its device and it is now in the process of a pilot clinical trial in patients experiencing pain from amputated limbs. That trial should yield results by year’s end, said CEO Jon Snyder.

Advertisement

Neuros raised $1.8 million in its first round of funding in 2009 and received a $1.5 million grant from the U.S. Department of Defense last year.

New investors RiverVest Venture Partners, Blue Tree Allied Angels and ModelVest participated in the round, as did previous investors Case Tech Ventures, JumpStart Ventures, NorthCoast Angel Fund, Ohio Tech Angel Fund, Queen City Angel Fund III and Physician Investment Group.

St. Louis, Missouri-based RiverVest has done well recently with its healthcare investments. The venture firm said it exited four healthcare portfolio companies last year with sales to Medtronic and Pfizer. Ohio Tech Angel Fund and Blue Tree Allied Angels were both recognized recently as two of the most active groups in healthcare deals over the last 12 months, according to the Q1 2012 Halo Report (pdf).

Boston Scientific already has a stake in the neurostimulation market with its implantable Precision Plus system and subsidiary Intelect Medical, a Cleveland Clinic spinoff it acquired for $78 million last year. Snyder couldn’t disclose any more details about BSX’s investment in Neuros.

Medtronic and St. Jude Medical are leaders in the growing neuromodulation market, which is also seeing activity from startups including SPR Therapeutics in Cleveland and Nervomatrix.

Read all of our Neuros Medical posts.

Veronica Combs contributed to this report.

[Photo from Neuros Medical]

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Deanna Pogorelc

By Deanna Pogorelc MedCity News

Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.
More posts by Author

0 comments